help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on October 29, 2004, doi:10.1164/rccm.200403-314OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200403-314OCv1
171/3/269    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morgan, R. K.
Right arrow Articles by Costello, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgan, R. K.
Right arrow Articles by Costello, R. W.
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 269-274, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200403-314OC


Original Article

Use of Sniff Nasal-Inspiratory Force to Predict Survival in Amyotrophic Lateral Sclerosis

Ross K. Morgan*, Stephen McNally*, Michael Alexander, Ronan Conroy, Orla Hardiman and Richard W. Costello

Departments of Medicine, Neurology, and Epidemiology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland

Correspondence and requests for reprints should be addressed to Richard W. Costello, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland. E-mail: rcostello{at}rcsi.ie

Respiratory muscle weakness is the usual cause of death in amyotrophic lateral sclerosis. The prognostic value of the forced vital capacity (FVC), mouth-inspiratory force, and sniff nasal-inspiratory force were established in a group of 98 patients with amyotrophic lateral sclerosis who were followed trimonthly for 3 years. Sniff nasal-inspiratory force correlated with the transdiaphragmatic pressure (r = 0.9, p < 0.01). Sniff nasal-inspiratory force was most likely to be recorded at the last visit (96% of cases), compared with either the FVC or mouth-inspiratory force (86% and 81%, respectively, p < 0.01). A sniff nasal-inspiratory force less than 40 cm H2O was significantly related with nocturnal hypoxemia. When sniff nasal-inspiratory force was less than 40 cm H2O, the hazard ratio for death was 9.1 (p = 0.001), and the median survival was 6 ± 0.3 months. The sensitivity of FVC < 50% for predicting 6-month mortality was 58% with a specificity of 96%, whereas sniff nasal-inspiratory force less than 40 H2O had a sensitivity of 97% and a specificity of 79% for death within 6 months. Thus the sniff nasal-inspiratory force test is a good measure of respiratory muscle strength in amyotrophic lateral sclerosis, it can be performed by patients with advanced disease, and it gives prognostic information.

Key Words: noninvasive ventilation • respiratory failure • respiratory muscle strength




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G Logroscino, B J Traynor, O Hardiman, A Chio', P Couratier, J D Mitchell, R J Swingler, E Beghi, and for EURALS
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 6 - 11.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J-W. Fitting
Sniff nasal inspiratory pressure: simple or too simple?
Eur. Respir. J., May 1, 2006; 27(5): 881 - 883.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Costello
Some Methodological Considerations Pertaining to Sniff Nasal Inspiratory Pressure (SNIP)
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 933 - 933.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J.-W. Fitting
Some Methodological Considerations Pertaining to Sniff Nasal Inspiratory Pressure (SNIP)
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 932 - 933.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  ATS Best of the Web